← Eichor
Study identifier: NCT06824103 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Condition: Graft vs. Host Disease · Chronic Graft vs. Host Disease · Corticosteroid-refractory Chronic Graft vs. Host Disease  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 4
Planned participants50
Who can joinAll sexes, 12 Years to 100 Years
Healthy volunteersNo

About this study

The purpose of the study is to assess the efficacy and safety of ruxolitinib in Chinese adult and pediatric participants aged 12 years or older with corticosteroid-refractory chronic graft vs. host disease (SR-cGvHD).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (22)

Novartis Investigative SiteHefei, Anhui, ChinaRecruiting
Novartis Investigative SiteGuangzhou, Guangdong, ChinaRecruiting
Novartis Investigative SiteGuangzhou, Guangdong, ChinaRecruiting
Novartis Investigative SiteNanning, Guangxi, ChinaRecruiting
Novartis Investigative SiteGuiyang, Guizhou, ChinaRecruiting
Novartis Investigative SiteShijiazhuang, Hebei, ChinaRecruiting
Novartis Investigative SiteZhengzhou, Henan, ChinaRecruiting
Novartis Investigative SiteWuhan, Hubei, ChinaRecruiting
Novartis Investigative SiteNanjing, Jiangsu, ChinaRecruiting
Novartis Investigative SiteXuzhou, Jiangsu, ChinaRecruiting
Novartis Investigative SiteNanchang, Jiangxi, ChinaRecruiting
Novartis Investigative SiteXian, Shanxi, ChinaRecruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06824103